Prenetics Global Limited (PRE)
PRE Stock Price Chart
Explore Prenetics Global Limited interactive price chart. Choose custom timeframes to analyze PRE price movements and trends.
PRE Company Profile
Discover essential business fundamentals and corporate details for Prenetics Global Limited (PRE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
16 Jul 2021
Employees
285.00
Website
https://www.prenetics.comCEO
Sheng Wu Yeung
Description
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE Financial Timeline
Browse a chronological timeline of Prenetics Global Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Oct 2025
EPS estimate is -$0.71, while revenue estimate is $21.70M.
Earnings released on 12 Jun 2025
EPS came in at -$0.80 falling short of the estimated -$0.77 by -3.90%, while revenue for the quarter reached $17.31M , beating expectations by +44.27%.
Earnings released on 5 Mar 2025
EPS came in at -$0.94 falling short of the estimated -$0.72 by -30.56%, while revenue for the quarter reached $10.50M , missing expectations by -12.50%.
Earnings released on 7 Oct 2024
EPS came in at -$0.88 falling short of the estimated -$0.86 by -2.33%, while revenue for the quarter reached $7.78M , beating expectations by +1.01%.
Earnings released on 27 Sept 2024
EPS came in at -$0.15 surpassing the estimated -$0.93 by +83.87%, while revenue for the quarter reached $5.94M , missing expectations by -22.84%.
Earnings released on 1 Apr 2024
EPS came in at -$0.52 surpassing the estimated -$4.80 by +89.17%, while revenue for the quarter reached $6.41M , missing expectations by -14.49%.
Earnings released on 26 Mar 2024
EPS came in at $0.90 surpassing the estimated -$4.80 by +118.75%, while revenue for the quarter reached $5.43M , missing expectations by -27.62%.
Earnings released on 20 Nov 2023
EPS came in at -$0.04 surpassing the estimated -$0.82 by +95.12%, while revenue for the quarter reached $4.87M , missing expectations by -52.30%.
Stock split effective on 14 Nov 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Sept 2023
EPS came in at -$0.15 falling short of the estimated -$0.05 by -200.00%, while revenue for the quarter reached $5.70M , missing expectations by -74.88%.
Earnings released on 5 Jun 2023
EPS came in at -$0.60 falling short of the estimated -$0.06 by -900.00%, while revenue for the quarter reached $17.70M , missing expectations by -33.31%.
Earnings released on 14 Mar 2023
EPS came in at $0.90 surpassing the estimated $0.09 by +900.00%, while revenue for the quarter reached $52.32M , missing expectations by -3.88%.
Earnings released on 10 Nov 2022
EPS came in at $4.50 surpassing the estimated -$1.95 by +330.77%, while revenue for the quarter reached $79.68M , beating expectations by +19.68%.
Earnings released on 9 Sept 2022
EPS came in at $0.60 surpassing the estimated -$0.62 by +196.77%, while revenue for the quarter reached $51.72M , missing expectations by -38.98%.
Stock split effective on 18 May 2022
Shares were split 129 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 May 2022
EPS came in at -$4.46 surpassing the estimated -$19.20 by +76.78%, while revenue for the quarter reached $92.04M , beating expectations by +0.58%.
Earnings released on 4 Mar 2022
EPS came in at -$10.87 , while revenue for the quarter reached $74.66M .
Earnings released on 31 Dec 2021
EPS came in at -$11.59 , while revenue for the quarter reached $64.72M .
Earnings released on 30 Jun 2021
EPS came in at -$1.32 , while revenue for the quarter reached $79.02M .
Earnings released on 31 Mar 2021
EPS came in at $0.26 , while revenue for the quarter reached $57.45M .
Earnings released on 31 Dec 2020
EPS came in at -$4.87 , while revenue for the quarter reached $27.27M .
Earnings released on 30 Sept 2020
EPS came in at $0.97 , while revenue for the quarter reached $25.93M .
PRE Stock Performance
Access detailed PRE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.